317:30-5-312. Treatment plan components and documentation requirements
(a) Treatment plan. The treatment plan is developed by a BCBA or a licensed psychologist from the FBA. The treatment plan shall:
(1) Be person-centered and individualized;
(2) Delineate the baseline levels of target behaviors;
(3) Specify long-term and short-term objectives that are defined in observable, measurable behavioral terms;
(4) Specify criteria that will be used to determine achievement of objectives;
(5) Include assessment(s) and treatment protocols for addressing each of the target behaviors such as including antecedent and consequence interventions, and teaching of replacement skills specific to the function of the identified maladaptive behaviors;
(6) Clearly identify the schedule of services planned and the individuals responsible for delivering the services, including frequent review of data on target behaviors and adjustments in the treatment plan and/or protocols by the BCBA or licensed psychologist as needed;
(7) Include training and supervision to enable board certified assistant behavior analysts (BCaBAs) and registered behavior technicians (RBTs) to implement assessment and treatment protocols;
(8) Include training and support to enable parents and other caregivers to participate in treatment planning and successfully reinforce the established treatment plan in the home and community settings;
(9) Include care coordination involving the parents or caregiver(s), school, state disability programs, and others as applicable; and
(10) Ensure that services are consistent with applicable professional standards and guidelines relating to the practice of applied behavior analysis as well as state Medicaid laws and regulations.
(b) Assessments. Initial assessments allow ABA providers to develop a treatment plan that is unique to the member and include all treatment recommendations and goals.
(1) The functional behavior assessment (FBA) serves as a critical component of the treatment plan and is conducted by a board-certified behavior analyst (BCBA) to identify the specific behavioral needs of the member. The FBA consists of:
(A) Description of the problematic behavior (topography, onset/offset, cycle, intensity, and severity);
(B) History of the problematic behavior (long-term and recent);
(C) Antecedent analysis (setting, people, time of day, and events);
(D) Consequence analysis; and
(E) Impression and analysis of the function of the problematic behavior.
(2) Other relevant assessments may be submitted in addition to the FBA for review by an OHCA reviewer and/or physician to support medical necessity criteria.
(c) Documentation requirements. ABA providers must:
(1) Document all ABA services in the member's record. Refer to OAC 317:30-5-248;
(2) Retain the member's records necessary to disclose the extent of services. Refer to OAC 317:30-3-15; and
(3) Release the medical information necessary for payment of a claim upon request. Refer to OAC 317:30-3-16.
(4) All assessment and treatment services must include the following:
(B) Start and stop time for each session/unit billed and physical location where service was provided;
(C) Signature of the provider;
(D) Credentials of provider;
(E) Specific problem(s), goals and/or objectives addressed;
(F) Methods used to address problem(s), goals and objectives;
(G) Progress made toward goals and objectives;
(H) Patient response to the session or intervention; and
(I) Any new problem(s), goals and/or objectives identified during the session.
(J) Treatment plans are not valid until all signatures are present. As used in this subsection, all signatures mean:
(i) The signature of acknowledgement of the supervising BCBA or licensed psychologist; and
(ii) The signature of assent of any minor who is age fourteen (14) or older; and
(iii) The signature of consent of:
(I) A parent or legal guardian of any minor; or
(II) If the minor documents a legal exception to parent or legal guardian consent, the excepted minor.
(iv) All signatures:
(I) Must clearly indicate that the signatories approve of and consent, assent, or acknowledge the treatment plan; and
(II) May be provided on a signature page applicable to both the assessment and the treatment plan, if the signed page clearly indicates approval of and consent, assent, or acknowledgment of both the assessment and the treatment plan.